Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
6h
EMA Committee Endorses AbbVie's Elahere in Ovarian Cancer
AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...
Pharmabiz
12h
EMA committee recommends marketing approval for AbbVie’s mirvetuximab soravtansine for the treatment of certain adult ovarian cancer
North Chicago, Illinois Monday, September 23, 2024, 13:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Shooting suspect left note
1951 kidnap victim found
Didn't authorize apology
Daylight saving time
Robinson loses key staff
California plastic bag ban
Astronauts return to Earth
Makes emergency landing
Tech ban proposed
No govt. shutdown for now
Economic speech this week
Dolphins legend Morris dies
Visits US ammunition plant
Bulls escape MA rodeo
Co-founder testifies
More troops to Middle East
To meet Vietnamese pres
SpaceX plans Mars missions
No. 1 at box office again
San Francisco homelessness
Ga. suspect's mom indicted
Free COVID-19 tests
Donlon's homes searched
Former WA governor dies
PM Modi visits US
ISR raids Al Jazeera office
Iran coal mine blast
Related topics
Ovarian cancer
AbbVie Inc.
Committee for Medicinal Products for Human Use
mirvetuximab
Feedback